BlueRock Therapeutics Compagnie réclamée
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
Lire la suite
Its exciting to be part of the journey to providing potentially life altering treatments to patients across multiple therapeutic domains.
Quelle est la meilleure partie de votre programme de rémunération?
base salary is the best part
Quelles sont les meilleures choses à propos de votre équipe?
passion for working; collaborative spirit, teams are not siloed
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
engagement and thoughtful communication on the company mission and status
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
The energy colleagues bring and willingness to work so collaboratively. Very refreshing.
Qu’est-ce qui vous rend le plus heureux au travail?
dynamic; the ability to contribute in so many ways, and also learning opportunities wrt iPSC's
Other Employee Reviews for BlueRock Therapeutics
×